Canopy Growth Corporation Stock (CGC) Jumps on Trump Marijuana Rescheduling Report — News, Forecasts, and What Investors Are Watching (Dec. 12, 2025)
Canopy Growth shares jumped about 21% in premarket trading Friday after reports said President Trump is expected to direct federal agencies to reclassify marijuana as a Schedule III drug. The move, first reported by the Washington Post and cited by Reuters, triggered a surge across US-listed cannabis stocks. No final decision has been made, according to a White House official.